<DOC>
	<DOCNO>NCT01806623</DOCNO>
	<brief_summary>As indication vulvovaginal candidiasis , single oral administration fluconazole 150 mg approve recommended guideline overseas . However Japan oral therapy antifungal triazole Fluconazole approve , topical therapy vaginal tablet , pessary cream use clinically . The purpose trial confirm efficacy safety single oral administration fluconazole 150 mg treatment vulvovaginal candidiasis Japanese patient .</brief_summary>
	<brief_title>The Study Of Fluconazole For Vulvovaginal Candidiasis</brief_title>
	<detailed_description />
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Patients clinical symptom sign vulvovaginal candidiasis . Patients test positive Candida fungal culture . Patients agree intercourse 28 day dose . Patients history hypersensitivity fluconazole . Patients severe renal dysfunction . Patients liver disorder .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>